Literature DB >> 33119866

Exosomes: Novel Players of Therapy Resistance in Neuroblastoma.

Heather Richard1, Arya Pokhrel1, Srinivas Chava2, Anup Pathania2, Santharam S Katta3, Kishore B Challagundla4,5.   

Abstract

Neuroblastoma is a solid tumor (a lump or mass), often found in the small glands on top of the kidneys, and most commonly affects infants and young children. Among neuroblastomas, high-risk neuroblastomas are very aggressive and resistant to most kinds of intensive treatment. Immunotherapy, which uses the immune system to fight against cancer, has shown great promise in treating many types of cancer. However, high-risk neuroblastoma is often resistant to this approach as well. Recent studies revealed that small vesicles known as exosomes, which are envelopes, could deliver a cargo of small RNA molecules and provide communication between neuroblastoma cells and the surrounding cells and trigger metastasis and resistance to immunotherapy. In this chapter, we describe the role of exosomes and small RNA molecules in the metastasis and regression of neuroblastoma and the potential therapeutic approaches to combat this menace.

Entities:  

Keywords:  Antibody-dependent cell cytotoxicity; Chemotherapy; Disialoganglioside; Exosome biogenesis; Exosomes; Extracellular vesicles; Immunotherapy; MYCN; Metastasis; Multivesicular bodies; Neuroblastoma; Non-coding RNAs; Pericytes; Tumor microenvironment; Tumor-associated monocytes

Year:  2020        PMID: 33119866      PMCID: PMC7775408          DOI: 10.1007/978-3-030-50224-9_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  41 in total

1.  Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.

Authors:  W B London; R P Castleberry; K K Matthay; A T Look; R C Seeger; H Shimada; P Thorner; G Brodeur; J M Maris; C P Reynolds; S L Cohn
Journal:  J Clin Oncol       Date:  2005-08-22       Impact factor: 44.544

2.  Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.

Authors:  David L Baker; Mary L Schmidt; Susan L Cohn; John M Maris; Wendy B London; Allen Buxton; Daniel Stram; Robert P Castleberry; Hiroyuki Shimada; Anthony Sandler; Robert C Shamberger; A Thomas Look; C Patrick Reynolds; Robert C Seeger; Katherine K Matthay
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

Review 3.  Neuroblastoma: A Tough Nut to Crack.

Authors:  Frank Speleman; Julie R Park; Tara O Henderson
Journal:  Am Soc Clin Oncol Educ Book       Date:  2016

Review 4.  Extracellular Vesicles: Unique Intercellular Delivery Vehicles.

Authors:  Sybren L N Maas; Xandra O Breakefield; Alissa M Weaver
Journal:  Trends Cell Biol       Date:  2016-12-13       Impact factor: 20.808

5.  Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury.

Authors:  Yanlu Zhang; Michael Chopp; Yuling Meng; Mark Katakowski; Hongqi Xin; Asim Mahmood; Ye Xiong
Journal:  J Neurosurg       Date:  2015-01-16       Impact factor: 5.115

Review 6.  Immunology and immunotherapy of neuroblastoma.

Authors:  Robert C Seeger
Journal:  Semin Cancer Biol       Date:  2011-09-28       Impact factor: 15.707

7.  Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease.

Authors:  Muhammad Aslam; Rajiv Baveja; Olin D Liang; Angeles Fernandez-Gonzalez; Changjin Lee; S Alex Mitsialis; Stella Kourembanas
Journal:  Am J Respir Crit Care Med       Date:  2009-08-27       Impact factor: 21.405

Review 8.  Advances in Risk Classification and Treatment Strategies for Neuroblastoma.

Authors:  Navin R Pinto; Mark A Applebaum; Samuel L Volchenboum; Katherine K Matthay; Wendy B London; Peter F Ambros; Akira Nakagawara; Frank Berthold; Gudrun Schleiermacher; Julie R Park; Dominique Valteau-Couanet; Andrew D J Pearson; Susan L Cohn
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

Review 9.  Exosome-Based Cell-Cell Communication in the Tumor Microenvironment.

Authors:  Joana Maia; Sergio Caja; Maria Carolina Strano Moraes; Nuno Couto; Bruno Costa-Silva
Journal:  Front Cell Dev Biol       Date:  2018-02-20

Review 10.  Exosomes: biogenesis, biologic function and clinical potential.

Authors:  Yuan Zhang; Yunfeng Liu; Haiying Liu; Wai Ho Tang
Journal:  Cell Biosci       Date:  2019-02-15       Impact factor: 7.133

View more
  2 in total

Review 1.  The Potential Role of Exosomes in the Treatment of Brain Tumors, Recent Updates and Advances.

Authors:  Zoufang Huang; Shayan Keramat; Mehrdad Izadirad; Zhe-Sheng Chen; Mohammad Soukhtanloo
Journal:  Front Oncol       Date:  2022-03-17       Impact factor: 5.738

2.  miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma.

Authors:  Anup S Pathania; Philip Prathipati; Omalla A Olwenyi; Srinivas Chava; Oghenetejiri V Smith; Subash C Gupta; Nagendra K Chaturvedi; Siddappa N Byrareddy; Don W Coulter; Kishore B Challagundla
Journal:  Mol Ther Oncolytics       Date:  2022-03-31       Impact factor: 6.311

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.